Cargando…

Feasibility of a randomised controlled trial of two types of written information for people with knee osteoarthritis

OBJECTIVE: Test the feasibility of conducting an individually randomised controlled trial recruiting people with knee osteoarthritis (OA) in community pharmacies and evaluate the impacts of a novel information booklet. DESIGN: People with knee OA were identified by pharmacy staff using clinical crit...

Descripción completa

Detalles Bibliográficos
Autores principales: Darlow, Ben, Brown, Melanie, Hudson, Ben, Frew, Gareth, Clark, Jane, Vincent, Loren, Abbott, J.Haxby, Briggs, Andrew M., Grainger, Rebecca, Marra, Carlo, McKinlay, Eileen, Stanley, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718297/
https://www.ncbi.nlm.nih.gov/pubmed/36475283
http://dx.doi.org/10.1016/j.ocarto.2022.100254
Descripción
Sumario:OBJECTIVE: Test the feasibility of conducting an individually randomised controlled trial recruiting people with knee osteoarthritis (OA) in community pharmacies and evaluate the impacts of a novel information booklet. DESIGN: People with knee OA were identified by pharmacy staff using clinical criteria and randomised to receive a novel information booklet (intervention) or the currently available written OA resource (active control). Mixed-methods process evaluation assessed participant recruitment, retention, and experience. Participant-reported outcome measures, assessing OA illness perceptions, OA knowledge, fear of movement, and pain when walking at baseline and 4-weeks, were analysed using linear regression models (adjusted for baseline). RESULTS: Of 72 eligible people, 64 were randomised to intervention (n ​= ​33) or control (n ​= ​31). The randomisation sequence was followed correctly and no protocol deviations identified. Mean recruitment rate was 2.7 participants per pharmacy per week. One-in-five participants had no educational qualifications and one-in-four had not received a knee OA diagnosis prior to the trial. Three meta-themes emerged from pharmacist and participant qualitative analysis: ‘pleased to be asked’; ‘easy process’; and ‘successful process’. Three participants were lost to follow-up. At 4 weeks, intervention arm Knee Osteoarthritis Knowledge Scale scores improved (mean difference ​= ​3.6, 95%CI 0.7 to 6.5). Brief Illness Perceptions Questionnaire scores were similar between groups (mean difference 0.4, 95%CI -3.7 to 4.5). CONCLUSION: It is feasible to conduct an individually randomised trial in community pharmacy, a potentially effective setting to initiate accessible OA care. A novel information booklet improved OA knowledge, but is unlikely to affect illness perceptions on its own.